NCT04248023

Brief Summary

Unhealthy alcohol use is the third leading preventable cause of death in the United States. Yet, primary care physicians do not, on average, screen for and address unhealthy alcohol use in their patient populations. By implementing practice changes to promote screening and treatment, patients stand to reduce unhealthy alcohol use and benefit from improved health outcomes. This project will provide a sample of Virginia primary care practices with a practice facilitator, practice specific resources, education on screening and counseling, and education on medication assisted therapy. The project will measure whether this change will improve screening rates and promote reduction of unhealthy alcohol use.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
13,680

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2020

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 27, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

January 30, 2020

Completed
6 months until next milestone

Study Start

First participant enrolled

July 15, 2020

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2022

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2023

Completed
Last Updated

July 25, 2023

Status Verified

July 1, 2023

Enrollment Period

2 years

First QC Date

January 27, 2020

Last Update Submit

July 21, 2023

Conditions

Keywords

Alcohol MisuseAlcohol AbusePractice FacilitationMotivational InterviewingPreventive Services

Outcome Measures

Primary Outcomes (2)

  • Screening for Unhealthy Alcohol Use

    This outcome will evaluate the percent of patients who were screened in clinic or report screening for alcohol use (numerator = intervention patients sampled who received counseling/ denominator = intervention patients who did not receive counseling at 3 time points.)

    6 months

  • Treatment for Unhealthy Alcohol Use

    This outcome will measure the percent of patients, screening positive for risky alcohol use, that receive any type of treatment including, but not limited to, counseling, brief intervention, motivational interviewing, referral, or medication assisted treatment.

    6 months

Secondary Outcomes (1)

  • Reduction of Unhealthy Alcohol Use

    6 months

Study Arms (2)

Intervention Practices

EXPERIMENTAL

Intervention practices will work with a practice facilitator to make practice specific changes to address unhealthy alcohol use.

Behavioral: Practice Facilitation

Control Practices

NO INTERVENTION

Control practices will continue to screening and address unhealthy alcohol use based on their existing practice patterns.

Interventions

A practice facilitator will be assigned the each participating practice to assist with the development of a workflow, screening process, counseling resources, and referral resources for unhealthy alcohol use. Practices in control group will receive delayed intervention at 3 months after their matched cohort of practices.

Intervention Practices

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Primary care practices
  • Ambulatory care practices
  • \. Patients 18 years and older and with an office visit at an included study site

You may not qualify if:

  • Practices that do not provide outpatient care
  • Practices that do not provide primary care
  • Patients under 18 years old
  • Patients without an office visit

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Virginia Ambulatory Care Outcomes Research Network

Richmond, Virginia, 23298, United States

Location

Virginia Commonwealth University

Richmond, Virginia, 23298, United States

Location

Related Publications (2)

  • Huffstetler AN, Villalobos G, Webel B, Rockwell MS, Funk A, Sabo RT, Epling JW, Brooks EM, Britz JB, Bortz BA, Svikis DS, Arias AJ, Tran RN, Krist AH. Practice Facilitation to Address Unhealthy Alcohol Use in Primary Care: A Cluster Randomized Clinical Trial. JAMA Health Forum. 2024 Aug 2;5(8):e242371. doi: 10.1001/jamahealthforum.2024.2371.

  • Huffstetler AN, Kuzel AJ, Sabo RT, Richards A, Brooks EM, Lail Kashiri P, Villalobos G, Arias AJ, Svikis D, Bortz BA, Edwards A, Epling J, Cohen DJ, Parchman ML, Winter J, Wessler P, Yu TJ, Krist AH. Practice facilitation to promote evidence-based screening and management of unhealthy alcohol use in primary care: a practice-level randomized controlled trial. BMC Fam Pract. 2020 May 20;21(1):93. doi: 10.1186/s12875-020-01147-4.

MeSH Terms

Conditions

Alcohol DrinkingAlcoholism

Condition Hierarchy (Ancestors)

Drinking BehaviorBehaviorAlcohol-Related DisordersSubstance-Related DisordersChemically-Induced DisordersMental Disorders

Study Officials

  • Alexander H Krist, MD, MPH

    Virginia Commonwealth University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Based on the intervention of practice facilitation, it is not able to blind practices or clinicians from the intervention.
Purpose
SCREENING
Intervention Model
PARALLEL
Model Details: This study is a practice level randomized controlled trial. 125 practices across Virginia will receive the intervention (practice facilitation to enhance screening and treatment of unhealthy alcohol use (UAU)) or act as a control group (will receive practice facilitation at 3 month lag behind intervention groups.) The investigators will survey 60 patients from each practice at three time intervals to evaluate the current state and what changes are implemented and reported over the course of the study. An additional 60 patient chart review from each practice will be preformed. The investigators will use an implementation-effectiveness design to measure outcomes. Effectiveness outcomes include increased screening rate of patients; increased treatment of any kind for patients with UAU; and reduction of UAU. Implementation outcomes will include the barriers and facilitators to screening and evaluating for UAU.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 27, 2020

First Posted

January 30, 2020

Study Start

July 15, 2020

Primary Completion

July 30, 2022

Study Completion

May 31, 2023

Last Updated

July 25, 2023

Record last verified: 2023-07

Locations